Inventor
CLEEMANN FELIX
DE24 patents
⚠️ This page may combine multiple inventors who share the name “CLEEMANN FELIX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASCENDIS PHARMA GROWTH DISORDERS AS
10 patentsUS10835578B2Nov 17, 2020
CNP prodrugs with large carrier moieties
ASCENDIS PHARMA GROWTH DISORDERS AS21 citations93
US11389511B2Jul 19, 2022
Controlled-release CNP agonists with reduced side-effects
ASCENDIS PHARMA GROWTH DISORDERS AS7 citations85
US11413351B2Aug 16, 2022
CNP prodrugs with carrier attachment at the ring moiety
ASCENDIS PHARMA GROWTH DISORDERS AS7 citations84
US11154593B2Oct 26, 2021
CNP prodrugs with large carrier moieties
ASCENDIS PHARMA GROWTH DISORDERS AS13 citations84
US11389510B2Jul 19, 2022
Controlled-release CNP agonists with low initial NPR-B activity
ASCENDIS PHARMA GROWTH DISORDERS AS5 citations83
US12083182B2Sep 10, 2024
Controlled-release CNP agonists with increased NEP stability
ASCENDIS PHARMA GROWTH DISORDERS AS3 citations74
US12156917B2Dec 3, 2024
CNP prodrugs with carrier attachment at the ring moiety
ASCENDIS PHARMA GROWTH DISORDERS AS2 citations73
US11311604B2Apr 26, 2022
Controlled-release CNP agonists with low NPR-C binding
ASCENDIS PHARMA GROWTH DISORDERS AS6 citations72
US12239689B2Mar 4, 2025
Controlled-release CNP agonists with low initial NPR-B activity
ASCENDIS PHARMA GROWTH DISORDERS AS1 citations64
US12544428B2Feb 10, 2026
Controlled-release CNP agonists with reduced side-effects
ASCENDIS PHARMA GROWTH DISORDERS AS0 citations62
ASCENDIS PHARMA BONE DISEASES AS
8 patentsUS11918628B2Mar 5, 2024
Controlled-release PTH compound
ASCENDIS PHARMA BONE DISEASES AS4 citations84
US11890326B2Feb 6, 2024
Controlled-release PTH compound
ASCENDIS PHARMA BONE DISEASES AS5 citations84
US11793861B2Oct 24, 2023
PTH prodrugs
ASCENDIS PHARMA BONE DISEASES AS5 citations84
US11759504B2Sep 19, 2023
PTH compounds with low peak-to-trough ratios
ASCENDIS PHARMA BONE DISEASES AS6 citations83
US11857603B2Jan 2, 2024
PTH compounds with low peak-to-trough ratios
ASCENDIS PHARMA BONE DISEASES AS5 citations72
US12214020B2Feb 4, 2025
PTH prodrugs
ASCENDIS PHARMA BONE DISEASES AS0 citations61
US12453778B2Oct 28, 2025
Incremental dose finding in controlled-release PTH compounds
ASCENDIS PHARMA BONE DISEASES AS0 citations50
US12403182B2Sep 2, 2025
Liquid pharmaceutical formulations of PTH conjugates
ASCENDIS PHARMA BONE DISEASES AS0 citations43